Your session is about to expire
← Back to Search
Other
Dexmedetomidine / Ketamine / Lidocaine for Temporomandibular Joint Disorder
Phase 2
Recruiting
Led By Jingping Wang, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours postoperatively
Awards & highlights
Study Summary
This trial will test whether patients who have surgery on their temporomandibular joint (TMJ) recover better when they do not receive opioids during anesthesia.
Eligible Conditions
- Temporomandibular Joint Disorder (TMJ Disorder)
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 48 hours postoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours postoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain Score
Secondary outcome measures
Incidence of Opioid Related Adverse Effects
Length of Stay
Pain Satisfaction
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Opioid-free AnesthesiaExperimental Treatment1 Intervention
Patients in this arm will not receiving opioids but the total intravenous anesthetic during surgery. Patients in this group will receive an infusion of lidocaine, ketamine, or dexmedetomidine supplemented with other intravenous analgesics and intravenous and inhaled anesthetics.
Group II: Standard AnesthesiaActive Control1 Intervention
Patients in this arm will undergo the standard of care and receive opioids as part of their anesthetic regimen.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,943 Previous Clinical Trials
13,200,929 Total Patients Enrolled
Jingping Wang, MDPrincipal InvestigatorMassachusetts General Hospital
Share this study with friends
Copy Link
Messenger